Kv7.4 channels participate in the control of rodent renal vascular resting tone
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Kv7.4 channels participate in the control of rodent renal vascular resting tone. / Salomonsson, Max; Brasen, Jens Christian; Braunstein, Thomas Hartig; Hagelqvist, Per Gustav; Holstein-Rathlou, Niels-Henrik; Sørensen, Charlotte Mehlin.
I: Acta Physiologica (Print), Bind 214, Nr. 3, 07.2015, s. 402-414.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Kv7.4 channels participate in the control of rodent renal vascular resting tone
AU - Salomonsson, Max
AU - Brasen, Jens Christian
AU - Braunstein, Thomas Hartig
AU - Hagelqvist, Per Gustav
AU - Holstein-Rathlou, Niels-Henrik
AU - Sørensen, Charlotte Mehlin
PY - 2015/7
Y1 - 2015/7
N2 - Aim: We tested the hypothesis that KV7 channels contribute to basal renal vascular tone and that they participate in agonist-induced renal vasoconstriction or vasodilation.Methods: KV7 channel subtypes in renal arterioles were characterized by immunofluorescence. Renal blood flow (RBF) was measured using an ultrasonic flow probe. The isometric tension of rat interlobar arteries was examined in a wire myograph. Mice afferent arteriolar diameter was assessed utilizing the perfused juxtamedullary nephron technique.Results: Immunofluorescence revealed that KV7.4 channels were expressed in rat afferent arterioles. The KV7 blocker XE991 dose-dependently increased the isometric tension of rat interlobar arteries and caused a small (approx. 4.5%) RBF reduction in vivo. Nifedipine abolished these effects. Likewise, XE991 reduced mouse afferent arteriolar diameter by approx. 5%. The KV7.2–5 stimulator flupirtine dose-dependently relaxed isolated rat interlobar arteries and increased (approx. 5%) RBF in vivo. The RBF responses to NE or Ang II administration were not affected by pre-treatment with XE991 or flupirtine. XE991 pre-treatment caused a minor augmentation of the acetylcholine-induced increase in RBF, while flupirtine pre-treatment did not affect this response.Conclusion: It is concluded that KV7 channels, via nifedipine sensitive channels, have a role in the regulation of basal renal vascular tone. There is no indication that KV7 channels have an effect on agonist-induced renal vasoconstriction while there is a small effect on acetylcholine-induced vasodilation.
AB - Aim: We tested the hypothesis that KV7 channels contribute to basal renal vascular tone and that they participate in agonist-induced renal vasoconstriction or vasodilation.Methods: KV7 channel subtypes in renal arterioles were characterized by immunofluorescence. Renal blood flow (RBF) was measured using an ultrasonic flow probe. The isometric tension of rat interlobar arteries was examined in a wire myograph. Mice afferent arteriolar diameter was assessed utilizing the perfused juxtamedullary nephron technique.Results: Immunofluorescence revealed that KV7.4 channels were expressed in rat afferent arterioles. The KV7 blocker XE991 dose-dependently increased the isometric tension of rat interlobar arteries and caused a small (approx. 4.5%) RBF reduction in vivo. Nifedipine abolished these effects. Likewise, XE991 reduced mouse afferent arteriolar diameter by approx. 5%. The KV7.2–5 stimulator flupirtine dose-dependently relaxed isolated rat interlobar arteries and increased (approx. 5%) RBF in vivo. The RBF responses to NE or Ang II administration were not affected by pre-treatment with XE991 or flupirtine. XE991 pre-treatment caused a minor augmentation of the acetylcholine-induced increase in RBF, while flupirtine pre-treatment did not affect this response.Conclusion: It is concluded that KV7 channels, via nifedipine sensitive channels, have a role in the regulation of basal renal vascular tone. There is no indication that KV7 channels have an effect on agonist-induced renal vasoconstriction while there is a small effect on acetylcholine-induced vasodilation.
U2 - 10.1111/apha.12525
DO - 10.1111/apha.12525
M3 - Journal article
C2 - 25965962
VL - 214
SP - 402
EP - 414
JO - Acta Physiologica
JF - Acta Physiologica
SN - 1748-1708
IS - 3
ER -
ID: 145842479